speb/financial-data huggingface dataset:
CMCSA balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 12410000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Current Assets: 29567000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Current Assets: 29567000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Current Debt: 5958000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Current Debt: 5958000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 5958000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 5958000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 4097000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 4097000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 4097000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 4097000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Current Liabilities: 33524000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 33524000000.00
CMCSA cash_flow (annual, 2025-12-31) — Deferred Income Tax: 2674000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -576000000.00
CMCSA cash_flow (annual, 2025-12-31) — Deferred Tax: 2674000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Deferred Tax: -576000000.00
CMCSA cash_flow (annual, 2025-12-31) — Depreciation: 9327000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Depreciation: 2393000000.00
CMCSA cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 16210000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 4187000000.00
CMCSA income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 16211000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 4188000000.00
CMCSA cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 16210000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 4187000000.00
CMCSA income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 16211000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 4188000000.00
CMCSA income_statement (annual, 2025-12-31) — Depreciation Income Statement: 9327000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 2393000000.00
CMCSA income_statement (annual, 2025-12-31) — Diluted Average Shares: 3709000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 3636000000.00
CMCSA income_statement (annual, 2025-12-31) — Diluted EPS: 5.39
CMCSA income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.60
CMCSA income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 19998000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 2168000000.00
CMCSA income_statement (annual, 2025-12-31) — EBIT: 30175000000.00
CMCSA income_statement (quarterly, 2025-12-31) — EBIT: 3285000000.00
CMCSA income_statement (annual, 2025-12-31) — EBITDA: 46386000000.00
CMCSA income_statement (quarterly, 2025-12-31) — EBITDA: 7473000000.00
CMCSA income_statement (annual, 2025-12-31) — Earnings From Equity Interest: -591000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: -279000000.00
CMCSA cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 42000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 7000000.00
CMCSA cash_flow (annual, 2025-12-31) — End Cash Position: 10559000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — End Cash Position: 10559000000.00
CMCSA cash_flow (annual, 2025-12-31) — Financing Cash Flow: -14346000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -3222000000.00
CMCSA cash_flow (annual, 2025-12-31) — Free Cash Flow: 19235000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 4368000000.00
CMCSA income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 10094000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 76000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -8000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -8000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Goodwill: 61600000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Goodwill: 61600000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 155579000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 155579000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 14582000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 14582000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Gross PPE: 126480000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Gross PPE: 126480000000.00
CMCSA income_statement (annual, 2025-12-31) — Gross Profit: 88756000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Gross Profit: 22005000000.00
CMCSA cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 755000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: -1623000000.00
CMCSA income_statement (annual, 2025-12-31) — Interest Expense: 4409000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Interest Expense: 1126000000.00
CMCSA income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 4409000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 1126000000.00
CMCSA cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 3871000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 1189000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Invested Capital: 195840000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Invested Capital: 195840000000.00
CMCSA cash_flow (annual, 2025-12-31) — Investing Cash Flow: -16157000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -4437000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Investments And Advances: 7952000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 7952000000.00
CMCSA cash_flow (annual, 2025-12-31) — Issuance Of Debt: 3494000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 1000000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Land And Improvements: 2300000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 2300000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Long Term Debt: 92979000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 92979000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 92979000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 92979000000.00
CMCSA cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 3494000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 1000000000.00
CMCSA cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -5740000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -1374000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Minority Interest: 473000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Minority Interest: 473000000.00
CMCSA income_statement (annual, 2025-12-31) — Minority Interests: 338000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Minority Interests: 97000000.00
CMCSA cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -647000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -9000000.00
CMCSA cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -7155000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -1537000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Net Debt: 89456000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Net Debt: 89456000000.00
CMCSA income_statement (annual, 2025-12-31) — Net Income: 19998000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Net Income: 2168000000.00
CMCSA income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 19998000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 2168000000.00
CMCSA income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 19660000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 2070000000.00
CMCSA income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 19998000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 2168000000.00
CMCSA income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 19998000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 2168000000.00
CMCSA cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 19660000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 2070000000.00
CMCSA income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 19660000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 2070000000.00
CMCSA cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -2658000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -724000000.00
CMCSA income_statement (annual, 2025-12-31) — Net Interest Income: -4409000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Net Interest Income: -1126000000.00
CMCSA cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -1302000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -76000000.00
CMCSA cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -2246000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -374000000.00
CMCSA cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -2246000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -374000000.00
CMCSA income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -4409000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -1126000000.00
CMCSA cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -51000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -102000000.00
CMCSA cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 200000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 121000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Net PPE: 65680000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Net PPE: 65680000000.00
CMCSA cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 0.00
CMCSA balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -58676000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -58676000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 27788000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 27788000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 27788000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 27788000000.00
CMCSA income_statement (annual, 2025-12-31) — Normalized EBITDA: 36292000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 7397000000.00
CMCSA income_statement (annual, 2025-12-31) — Normalized Income: 12296278000.00
CMCSA income_statement (quarterly, 2025-12-31) — Normalized Income: 2095132931.91
CMCSA cash_flow (annual, 2025-12-31) — Operating Cash Flow: 33643000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 8841000000.00
CMCSA cash_flow (annual, 2025-12-31) — Operating Gains Losses: -8853000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 429000000.00
CMCSA income_statement (annual, 2025-12-31) — Operating Income: 20670000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Operating Income: 3486000000.00
CMCSA income_statement (annual, 2025-12-31) — Operating Revenue: 123707000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Operating Revenue: 32310000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 3604212627.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 3604212627.00
CMCSA balance_sheet (annual, 2025-12-31) — Other Current Assets: 6217000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 6217000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 1000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 1000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -8000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -8000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Other Equity Interest: -1000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: -1000000.00
CMCSA income_statement (annual, 2025-12-31) — Other Income Expense: 9503000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Other Income Expense: -203000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 93979000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 93979000000.00
CMCSA cash_flow (annual, 2025-12-31) — Other Non Cash Items: 487000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 127000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 13877000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 13877000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 20964000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 20964000000.00
CMCSA income_statement (annual, 2025-12-31) — Other Operating Expenses: 43013000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 11904000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Other Properties: 94800000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Other Properties: 94800000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Payables: 11058000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Payables: 11058000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 23468000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 23468000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CMCSA income_statement (annual, 2025-12-31) — Pretax Income: 25766000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Pretax Income: 2159000000.00
CMCSA cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: -7155000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: -1537000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Properties: 0.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CMCSA cash_flow (annual, 2025-12-31) — Purchase Of Business: -1317000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -35000000.00
CMCSA cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -2658000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -724000000.00
CMCSA cash_flow (annual, 2025-12-31) — Purchase Of Investment: -1302000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -76000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Receivables: 13869000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Receivables: 13869000000.00
CMCSA income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 34952000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 10306000000.00
CMCSA income_statement (annual, 2025-12-31) — Reconciled Depreciation: 16210000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 4187000000.00
CMCSA cash_flow (annual, 2025-12-31) — Repayment Of Debt: -5740000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -1374000000.00
CMCSA cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -7155000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -1537000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Retained Earnings: 66675000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 66675000000.00
CMCSA cash_flow (annual, 2025-12-31) — Sale Of Business: 670000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Sale Of Business: 26000000.00
CMCSA cash_flow (annual, 2025-12-31) — Sale Of Investment: 0.00
CMCSA income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 8862000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 2427000000.00
CMCSA income_statement (annual, 2025-12-31) — Selling General And Administration: 8862000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Selling General And Administration: 2427000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Share Issued: 4523238982.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Share Issued: 4523238982.00
CMCSA cash_flow (annual, 2025-12-31) — Stock Based Compensation: 1288000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 274000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Stockholders Equity: 96903000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 96903000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Tangible Book Value: -58676000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -58676000000.00
CMCSA income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 2392278000.00
CMCSA income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 3132931.91
CMCSA income_statement (annual, 2025-12-31) — Tax Provision: 6106000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Tax Provision: 89000000.00
CMCSA income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.24
CMCSA income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.04
CMCSA balance_sheet (annual, 2025-12-31) — Total Assets: 272631000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Total Assets: 272631000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Total Capitalization: 189882000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 189882000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Total Debt: 98937000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Total Debt: 98937000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 97376000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 97376000000.00
CMCSA income_statement (annual, 2025-12-31) — Total Expenses: 103037000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Total Expenses: 28824000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 175255000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 175255000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 243088000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 243088000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 141731000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 141731000000.00
CMCSA income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 20672000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 3488000000.00
CMCSA income_statement (annual, 2025-12-31) — Total Unusual Items: 10094000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Total Unusual Items: 76000000.00
CMCSA income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 10094000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 76000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 919026355.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 919026355.00
CMCSA balance_sheet (annual, 2025-12-31) — Treasury Stock: 7517000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 7517000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Working Capital: -3957000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Working Capital: -3957000000.00
CMCSA income_statement (quarterly, 2026-03-31) — +Operating Expense: 16438000000.00
CMCSA income_statement (quarterly, 2026-03-31) — +Total Revenue: 31457000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 11977000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 14078000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -61274000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 37543000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -697000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Amortization: 1533000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 1533000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 1533000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Amortization Of Intangibles Income Statement: 1533000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Basic Average Shares: 3597000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Basic EPS: 0.60
CMCSA cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 10559000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -2990000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -2351000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Capital Stock: 45000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 9468000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 9468000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -1248000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -5008000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -2919000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 6891000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 375000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -673000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 1119000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Change In Receivables: -1376000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -555000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Changes In Cash: -1036000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Common Stock: 45000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -1248000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 88274000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -1502000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 10884000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 11932000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Current Assets: 28822000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Current Debt: 5394000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 5394000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 4006000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 4006000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 33308000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 730000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Deferred Tax: 730000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Depreciation: 2333000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 3865000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 3866000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 3865000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 3866000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 2333000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 3617000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.60
CMCSA income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 2174000000.00
CMCSA income_statement (quarterly, 2026-03-31) — EBIT: 3827000000.00
CMCSA income_statement (quarterly, 2026-03-31) — EBITDA: 7693000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: -391000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -6000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — End Cash Position: 9517000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -5008000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 3901000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 82000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -399000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Goodwill: 53400000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 144230000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 14775000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Gross PPE: 126746000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Gross Profit: 20573000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Interest Expense: 1094000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 1094000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Invested Capital: 182886000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -2919000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 7450000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 1990000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 89218000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 89218000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 1990000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -3182000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Minority Interest: 266000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Minority Interests: 147000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 32000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -1502000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Net Debt: 85144000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Net Income: 2174000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 2174000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 2027000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 2174000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 2174000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 2027000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 2027000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: -639000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Net Interest Income: -1094000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -237000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -1192000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -1192000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -1094000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -1066000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 276000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Net PPE: 65472000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -55956000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 28227000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 28227000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 7611000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Normalized Income: 2113182583.24
CMCSA cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 6891000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 263000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Operating Income: 4135000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Operating Revenue: 31457000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 3576868808.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 5276000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 5394000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: -1000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -399000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Other Income Expense: -309000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 90830000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 134000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 14054000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 20709000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 10408000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Payables: 11977000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 23909000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CMCSA income_statement (quarterly, 2026-03-31) — Pretax Income: 2733000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: -1502000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Purchase Of Business: 0.00
CMCSA cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -639000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -237000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Receivables: 14078000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 10885000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 3865000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -3182000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -1502000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 58602000000.00
CMCSA cash_flow (quarterly, 2026-03-31) — Sale Of Business: 32000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 2164000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Selling General And Administration: 2164000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Share Issued: 4495895163.00
CMCSA cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 427000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 88274000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -55956000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 21182583.24
CMCSA income_statement (quarterly, 2026-03-31) — Tax Provision: 706000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.26
CMCSA balance_sheet (quarterly, 2026-03-31) — Total Assets: 260002000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 177492000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Total Debt: 94612000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 88540000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Total Expenses: 27322000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 171462000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 231206000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 138154000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 4135000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Total Unusual Items: 82000000.00
CMCSA income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 82000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 919026355.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 7517000000.00
CMCSA balance_sheet (quarterly, 2026-03-31) — Working Capital: -4486000000.00
CMCSA income_statement (quarterly, 2026-06-30) — +Operating Expense: 16391000000.00
CMCSA income_statement (quarterly, 2026-06-30) — +Total Revenue: 29940000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Accounts Payable: 11864000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Accounts Receivable: 13955000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Accumulated Depreciation: -62017000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Additional Paid In Capital: 37680000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Allowance For Doubtful Accounts Receivable: -675000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Amortization: 1297000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Amortization Cash Flow: 1296000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Amortization Of Intangibles: 1296000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Amortization Of Intangibles Income Statement: 1297000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Basic Average Shares: 3564000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Basic EPS: 0.99
CMCSA cash_flow (quarterly, 2026-06-30) — Beginning Cash Position: 9517000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Capital Expenditure: -3489000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Capital Expenditure Reported: -2902000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Capital Stock: 45000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Cash And Cash Equivalents: 7661000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Cash Cash Equivalents And Short Term Investments: 7661000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Cash Dividends Paid: -1184000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Cash Flow From Continuing Financing Activities: -6305000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Cash Flow From Continuing Investing Activities: -3572000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Cash Flow From Continuing Operating Activities: 8091000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Change In Other Current Assets: 498000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Change In Other Working Capital: -218000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Change In Payables And Accrued Expense: -161000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Change In Receivables: 38000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Change In Working Capital: 157000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Changes In Cash: -1784000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Common Stock: 45000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Common Stock Dividend Paid: -1184000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Common Stock Equity: 89763000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Common Stock Payments: -1005000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Cost Of Revenue: 8389000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Current Accrued Expenses: 11325000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Current Assets: 26335000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Current Debt: 6117000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Current Debt And Capital Lease Obligation: 6117000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Current Deferred Liabilities: 3787000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Current Deferred Revenue: 3787000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Current Liabilities: 33093000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Deferred Income Tax: 697000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Deferred Tax: 697000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Depreciation: 2391000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Depreciation Amortization Depletion: 3688000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Depreciation Amortization Depletion Income Statement: 3688000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Depreciation And Amortization: 3688000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Depreciation And Amortization In Income Statement: 3688000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Depreciation Income Statement: 2391000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Diluted Average Shares: 3570000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Diluted EPS: 0.99
CMCSA income_statement (quarterly, 2026-06-30) — Diluted NI Availto Com Stockholders: 3526000000.00
CMCSA income_statement (quarterly, 2026-06-30) — EBIT: 5664000000.00
CMCSA income_statement (quarterly, 2026-06-30) — EBITDA: 9352000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Earnings From Equity Interest: 285000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Effect Of Exchange Rate Changes: 2000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — End Cash Position: 7735000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Financing Cash Flow: -6305000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Free Cash Flow: 4603000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Gain On Sale Of Security: 219000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Gains Losses Not Affecting Retained Earnings: -743000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Goodwill: 53100000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Goodwill And Other Intangible Assets: 142619000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Gross Accounts Receivable: 14630000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Gross PPE: 128144000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Gross Profit: 21551000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Interest Expense: 1052000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Interest Expense Non Operating: 1052000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Invested Capital: 180144000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Investing Cash Flow: -3572000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Investments And Advances: 7828000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Issuance Of Debt: 0.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Long Term Debt: 84264000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Long Term Debt And Capital Lease Obligation: 84264000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Long Term Debt Issuance: 0.00
CMCSA cash_flow (quarterly, 2026-06-30) — Long Term Debt Payments: -4162000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Minority Interest: 192000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Minority Interests: 107000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Net Business Purchase And Sale: 74000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Net Common Stock Issuance: -1005000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Net Debt: 82720000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Net Income: 3526000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Net Income Common Stockholders: 3526000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Net Income Continuous Operations: 3418000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Net Income From Continuing And Discontinued Operation: 3526000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Net Income From Continuing Operation Net Minority Interest: 3526000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Net Income From Continuing Operations: 3418000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Net Income Including Noncontrolling Interests: 3419000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Net Intangibles Purchase And Sale: -587000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Net Interest Income: -1052000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Net Investment Purchase And Sale: -248000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Net Issuance Payments Of Debt: -4162000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Net Long Term Debt Issuance: -4162000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Net Non Operating Interest Income Expense: -1052000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Net Other Financing Charges: 46000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Net Other Investing Changes: 91000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Net PPE: 66127000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Net Tangible Assets: -52856000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Non Current Deferred Liabilities: 28940000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Non Current Deferred Taxes Liabilities: 28940000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Normalized EBITDA: 9133000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Normalized Income: 3363696877.71
CMCSA cash_flow (quarterly, 2026-06-30) — Operating Cash Flow: 8092000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Operating Gains Losses: -347000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Operating Income: 5160000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Operating Revenue: 29940000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Ordinary Shares Number: 3546403872.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Other Current Assets: 4719000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Other Equity Adjustments: -743000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Other Income Expense: 504000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Other Intangible Assets: 89519000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Other Non Cash Items: 120000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Other Non Current Assets: 14669000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Other Non Current Liabilities: 21296000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Other Operating Expenses: 10445000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Payables: 11864000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Payables And Accrued Expenses: 23189000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Preferred Stock: 0.00
CMCSA income_statement (quarterly, 2026-06-30) — Pretax Income: 4612000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Purchase Of Business: 0.00
CMCSA cash_flow (quarterly, 2026-06-30) — Purchase Of Intangibles: -587000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Purchase Of Investment: -248000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Receivables: 13955000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Reconciled Cost Of Revenue: 8389000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Reconciled Depreciation: 3688000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Repayment Of Debt: -4162000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Repurchase Of Capital Stock: -1005000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Retained Earnings: 60298000000.00
CMCSA cash_flow (quarterly, 2026-06-30) — Sale Of Business: 74000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Selling And Marketing Expense: 2258000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Selling General And Administration: 2258000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Share Issued: 3546403872.00
CMCSA cash_flow (quarterly, 2026-06-30) — Stock Based Compensation: 359000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Stockholders Equity: 89763000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Tangible Book Value: -52856000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Tax Effect Of Unusual Items: 56696877.71
CMCSA income_statement (quarterly, 2026-06-30) — Tax Provision: 1194000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Tax Rate For Calcs: 0.26
CMCSA balance_sheet (quarterly, 2026-06-30) — Total Assets: 257548000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Total Capitalization: 174027000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Total Debt: 90381000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Total Equity Gross Minority Interest: 89955000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Total Expenses: 24780000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Total Liabilities Net Minority Interest: 167593000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Total Non Current Assets: 231243000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Total Non Current Liabilities Net Minority Interest: 134500000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Total Operating Income As Reported: 5160000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Total Unusual Items: 219000000.00
CMCSA income_statement (quarterly, 2026-06-30) — Total Unusual Items Excluding Goodwill: 219000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Treasury Stock: 7517000000.00
CMCSA balance_sheet (quarterly, 2026-06-30) — Working Capital: -6758000000.00
CMCT income_statement (annual, 2021-12-31) — Average Dilution Earnings: 0.00
CMCT cash_flow (annual, 2021-12-31) — Common Stock Issuance: 78825000.00
CMCT cash_flow (annual, 2021-12-31) — Common Stock Payments: 0.00
CMCT income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 0.00
CMCT cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 108654000.00
CMCT cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 78825000.00
CMCT cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: 35396000.00
CMCT balance_sheet (annual, 2021-12-31) — Preferred Shares Number: 5387160.00
CMCT cash_flow (annual, 2021-12-31) — Preferred Stock Issuance: 29829000.00
CMCT cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: 0.00
CMCT cash_flow (annual, 2021-12-31) — Purchase Of Investment Properties: -2933000.00
CMCT cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 35396000.00
CMCT income_statement (annual, 2022-12-31) — +Operating Expense: 30787000.00
CMCT income_statement (annual, 2022-12-31) — +Total Revenue: 101906000.00
CMCT balance_sheet (annual, 2022-12-31) — Accounts Payable: 107220000.00
CMCT balance_sheet (annual, 2022-12-31) — Accounts Receivable: 3780000.00
CMCT balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 861721000.00
CMCT cash_flow (annual, 2022-12-31) — Amortization Of Securities: 48000.00
CMCT cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 259000.00
CMCT income_statement (annual, 2022-12-31) — Average Dilution Earnings: -9000.00
CMCT income_statement (annual, 2022-12-31) — Basic Average Shares: 927.00